Marijuana Stocks & Public Companies

Week in Review: NV cannabis licensing gripes, Connecticut permits more MMJ dispensaries & Q3 earnings roundup

Nevada issues 61 additional provisional recreational marijuana retail permits, Connecticut doubles the number of medical cannabis dispensary licenses in the state, and some publicly traded MJ firms release third-quarter results. Here’s a closer look at some notable developments in the marijuana industry this week. Nevada licensing controversy Nevada issued 61 provisional adult-use retail licenses, which […]

Read More

Acreage inks $160 million acquisition of Oregon cannabis firm

Acreage Holdings has inked a $160 million deal to acquire Form Factory, a Portland, Oregon-based marijuana infused edibles manufacturer and distributor. The all-stock deal will boost Acreage’s footprint from 18 to 19 states and position the firm as a multistate consumer packaged goods firm, said George Allen, president of the New York-based company (CSE: ACRG.U). […]

Read More

Regulator warns Canadian marijuana firms against ‘problematic practices’

Canada’s stock market regulator warned publicly traded companies in emerging industries such as cannabis and fintech against “problematic promotional activities” that could artificially increase share prices and put investors at risk. The warning from the Canadian Securities Administrators (CSA) – an umbrella organization for provincial securities regulators – came amid already highly volatile cannabis stock […]

Read More

Aphria fallout: 5 takeaways on the report that sent this cannabis stock plunging

The blows to Aphria’s stock continued Wednesday as the Canadian cannabis giant’s share price tumbled in the wake of a scathing short-seller report. Aphria’s stock (Nasdaq: APHA) closed Wednesday at $4.51 – down more than 25% for the day. The company has been on the defensive since Monday, refuting claims lobbed by short sellers Quintessential […]

Read More

Aphria warned by Health Canada about ‘noncompliance’ in June

Beleaguered Canadian cannabis giant Aphria was given a noncompliance rating and issued a warning letter by Health Canada in June over “critical” findings discovered in a routine annual inspection. During the inspection, Health Canada identified three critical items related to recordkeeping, good production practices and sanitation and maintenance of Aphria’s facility in Leamington, Ontario, the […]

Read More

Multistate cannabis firm Cresco Labs launches trading on CSE

Chicago-based Cresco Labs began trading Monday on the Canadian Securities Exchange, adding its name to the rapidly growing list of U.S.-based firms that are going public in Canada. Here’s what you need to know: Cresco Labs will trade on the CSE under the ticker symbol CL. Shares of the multistate marijuana company opened at 8 Canadian […]

Read More

Arizona marijuana consulting firm acquired by Item 9 Labs

One of the longest-operating cannabis consulting firms in Arizona, Dispensary Permits, has been acquired by publicly traded corporation Item 9 Labs for $1.5 million and 3 million shares of stock. Here are the basics of the deal: Item 9 Labs (OTC: INLB) said in a news release the agreement includes ownership of websites dispensarypermits.com and dispensarytemplates.com, along with […]

Read More

US cannabis edibles firm Dixie Brands debuts trading on CSE

Denver-based Dixie Brands began trading Thursday on the Canadian Securities Exchange, joining a rapidly growing list of U.S.-based marijuana firms that have looked north of the border to raise capital to grow and compete. Shares of Dixie – trading under the ticker symbol DIXI.U – opened at 1.05 Canadian dollars (79 cents). The move follows the […]

Read More

Multistate marijuana firm Cura Partners inks $75 million private placement

Oregon-based Cura Partners, a multistate cannabis firm, has completed a $75 million private placement. The capital will be used for product development, marketing and expanding operational infrastructure, the company said. The raise included investments from institutional investors in North America, Asia, Australia and the United Kingdom, “reflecting increasing global interest in the cannabis industry,” Cura […]

Read More